170 related articles for article (PubMed ID: 25223437)
41. Multiple Endocrine Neoplasia: Genetics and Clinical Management.
Norton JA; Krampitz G; Jensen RT
Surg Oncol Clin N Am; 2015 Oct; 24(4):795-832. PubMed ID: 26363542
[TBL] [Abstract][Full Text] [Related]
42. [Multiple Endocrine Neoplasia].
Uchino S; Ito A
Gan To Kagaku Ryoho; 2019 Jul; 46(7):1114-1118. PubMed ID: 31296813
[TBL] [Abstract][Full Text] [Related]
43. Medullary thyroid cancer.
Clayman GL; el-Baradie TS
Otolaryngol Clin North Am; 2003 Feb; 36(1):91-105. PubMed ID: 12803011
[TBL] [Abstract][Full Text] [Related]
44. Hereditary medullary thyroid carcinoma.
Vasen HF; Vermey A
Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
[TBL] [Abstract][Full Text] [Related]
45. [Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].
Wohllk N; Becker P; Véliz J; Pineda G
Rev Med Chil; 2000 Jul; 128(7):791-800. PubMed ID: 11050843
[TBL] [Abstract][Full Text] [Related]
46. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
47. Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1).
Hai N; Kosugi S
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():47s-51s. PubMed ID: 10914990
[TBL] [Abstract][Full Text] [Related]
48. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
49. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
50. Multiple endocrine neoplasms.
Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):149-63. PubMed ID: 18328987
[TBL] [Abstract][Full Text] [Related]
51. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
52. Endocrine surgical aspects of multiple endocrine neoplasia syndromes in children.
Harrison B
Horm Res; 2007; 68 Suppl 5():105-6. PubMed ID: 18174722
[TBL] [Abstract][Full Text] [Related]
53. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
54. [Genetics of multiple endocrine neoplasies: clinical implications].
Igaz P; Gaillard RC
Rev Med Suisse; 2005 Feb; 1(6):408-13. PubMed ID: 15786644
[TBL] [Abstract][Full Text] [Related]
55. Multiple endocrine neoplasia.
Thakker RV
Horm Res; 2001; 56 Suppl 1():67-72. PubMed ID: 11786689
[TBL] [Abstract][Full Text] [Related]
56. Overview of Genetically Determined Diseases/Multiple Endocrine Neoplasia Syndromes Predisposing to Endocrine Tumors.
Decmann A; Patócs A; Igaz P
Exp Suppl; 2019; 111():105-127. PubMed ID: 31588530
[TBL] [Abstract][Full Text] [Related]
57. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
Calender A; Giraud S; Schuffenecker I; Lenoir GM; Gaudray P; Courseaux A; Porchet N; Aubert JP; Zhang CX
Horm Res; 1997; 47(4-6):199-210. PubMed ID: 9167953
[TBL] [Abstract][Full Text] [Related]
58. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
[TBL] [Abstract][Full Text] [Related]
59. Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
J Endocr Soc; 2018 Aug; 2(8):933-943. PubMed ID: 30087948
[TBL] [Abstract][Full Text] [Related]
60. Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.
Ilanchezhian M; Khan S; Okafor C; Glod J; Del Rivero J
Horm Metab Res; 2020 Aug; 52(8):588-597. PubMed ID: 32299110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
